Erratum: Activation of the JAK/STAT pathway in Behcet's disease (Genes and Immunity (2015) 16 DOI: 170-175; doi:10.1038/gene.2014.64);Activation of the JAK/STAT pathway in Behcet's disease

Genes and Immunity

Volumn 16, Issue 2, 2015, Pages 170-175

  Tulunay, A ^a   Dozmorov, M G ^b,c   Ture Ozdemir, F ^a   Yilmaz, V ^d   Eksioglu Demiralp, E ^a   Alibaz Oner, F ^a   Ozen, G ^a   Wren, J D ^b   Saruhan Direskeneli, G ^d   Sawalha, A H ^e   Direskeneli, H ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d ISTANBUL UNIVERSITY   (Turkey)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; JANUS KINASE; JANUS KINASE 1; MESSENGER RNA; PHYTOHEMAGGLUTININ; PREDNISOLONE; STAT PROTEIN; STAT3 PROTEIN; INTERLEUKIN DERIVATIVE; JAK1 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ADULT; ARTICLE; BEHCET DISEASE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; MICROARRAY ANALYSIS; MICROCHIP ANALYSIS; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN FOLDING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; ENZYMOLOGY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; METABOLISM;

ADULT; ANTIGENS, CD14; BEHCET SYNDROME; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERLEUKINS; JANUS KINASE 1; MALE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84938494345     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.80     Document Type: Erratum

References (37)

1. Direskeneli H. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 2006; 45: 1461-1465.
2. Hughes T, Coit P, Adler A, Yilmaz V, Aksu K, Düzgün N et al. Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease. Nat Genet 2013; 45: 319-324.
3. Frassanito M, Dammacco R, Cafforio P, Dammacco F. Th1 polarization of the immune response in Behcet's disease. Arthritis Rheum 1999; 42: 1967-1974.
4. Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol 2005; 139: 371-378.
5. Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S et al. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 2009; 5: 325-331.
6. Hreggvidsdottir HS, Noordenbos T, Baeten DL. Inflammatory pathways in spondyloarthritis. Mol Immunol 2014; 57: 28-37.
7. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al. Genomewide association study identifies variants in the MHC class I, IL10, and IL23RIL12RB2 regions associated with Behcet's disease. Nat Genet 2010; 42: 698-702.
8. Hamzaoui K. Th17 cells in Behcet's disease: a new immunoregulatory axis. Clin Exp Rheumatol 2011; 29: S71-S76.
9. Direskeneli H, Fujita H, Akdis CA. Regulation of TH17 and regulatory T cells in patients with Behcet disease. J Allergy Clin Immunol 2011; 128: 665-666.
10. Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci 2008; 49: 3058-3064.
11. Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease. J Allergy Clin Immunol 2011; 128: 655-664.
12. Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A et al. Expression of Th-17 and RORgammat mRNA in Behcet's Disease. Med Sci Monit 2011; 17: CR227-CR234.
13. Liu X, Yang P, Wang C, Li F, Kijlstra A. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease. Rheumatology (Oxford) 2011; 50: 293-298.
14. Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M et al. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet's disease. Arthritis Res Ther 2012; 14: R99.
15. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J Immunol 2007; 178: 2623-2629.
16. O'Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 2013; 368: 161-170.
17. Coskun M, Salem M, Pedersen J, Nielsen OH. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res 2013; 76: 1-8.
18. Xavier JM, Krug T, Davatchi F, Shahram F, Fonseca BV, Jesus G et al. Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behcet's disease susceptibility. J Mol Med (Berl) 2013; 91: 1013-1023.
19. O'Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012; 36: 542-550.
20. Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010; 32: 605-615.
21. Kim J, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L et al. Imbalance of Th17 to Th1 cells in Behcet's disease. Clin Exp Rheumatol 2010; 28(4 Suppl 60): S16-S19.
22. Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S et al. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-gamma in patients with Behcet's disease. Clin Exp Immunol 2012; 168: 68-74.
23. Na SY, Park MJ, Park S, Lee ES. Up-regulation of Th17 and related cytokines in Behcet's disease corresponding to disease activity. Clin Exp Rheumatol 2013; 31(3 Suppl 77): 32-40.
24. Akman-Demir G, Tüzün E, Içöz S, Yeşilot N, Yentür SP, Kürtüncü M et al. Interleukin-6 in neuro-Behcet's disease: association with disease subsets and long-term outcome. Cytokine 2008; 44: 373-376.
25. Qi J, Tüzün E, Içöz S, Yeşilot N, Yentür SP, Kürtüncü M et al. Increased Notch pathway activation in Behcet's disease. Rheumatology (Oxford) 2014; 44: 373-376.
26. Yang J, Stark GR. Roles of unphosphorylated STATs in signaling. Cell Res 2008; 18: 443-451.
27. Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007; 21: 1396-1408.
28. Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG et al. Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem 2012; 287: 14192-14200.
29. Hou S, Qi J, Zhang Q, Liao D, Li Q, Hu K et al. Genetic variants in the JAK1 gene confer higher risk of Behcet's disease with ocular involvement in Han Chinese. Hum Genet 2013; 132: 1049-1058.
30. Hu K, Hou S, Jiang Z, Kijlstra A, Yang P. JAK2 and STAT3 polymorphisms in a Han Chinese population with Behcet's disease. Invest Ophthalmol Vis Sci 2012; 53: 538-541.
31. Cenit MC, Ortego-Centeno N, Raya E, Callejas JL, García-Hernandez FJ, Castillo-Palma MJ, Fernandez-Sueiro JL et al. Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease. Hum Immunol 2013; 74: 230-233.
32. Oh HM, Ortego-Centeno N, Raya E, Callejas JL, García-Hernandez FJ, Castillo-Palma MJ et al. Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms. J Immunol 2011; 187: 3338-3346.
33. Kovacic JC, Gupta R, Lee AC, Ma M, Fang F, Tolbert CN et al. Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J Clin Invest 2010; 120: 303-314.
34. Yeilding N, Szapary P, Brodmerkel C, Benson J, Plotnick M, Zhou H et al. Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives-an update. Ann N Y Acad Sci 2012; 1263: 1-12.
35. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.Lancet 1990; 335: 1078-1080.
36. R Development Core Team. R: a language and environment for statistical computing. 2013, R Foundation for Statistical Computing: Vienna, Austria.
37. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.